$275.9 M

ENZ Mkt cap, 14-Jun-2018

$80.3 M

Enzo Biochem Revenue Q3, 2018
Enzo Biochem Gross profit (Q3, 2018)45.5 M
Enzo Biochem Gross profit margin (Q3, 2018), %56.7%
Enzo Biochem Net income (Q3, 2018)-4.6 M
Enzo Biochem EBIT (Q3, 2018)-6.5 M
Enzo Biochem Cash, 30-Apr-201862.6 M

Enzo Biochem Revenue Breakdown

Embed Graph

Enzo Biochem revenue breakdown by business segment: 69.0% from Clinical Labs and 31.0% from Life Sciences

Enzo Biochem Financials

Enzo Biochem Income Statement

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

93.7 m95.9 m97.6 m102.8 m

Revenue growth, %

2%2%5%

R&D expense

3.5 m

Operating expense total

3.5 m

EBIT

(19 m)(10.2 m)(1.2 m)47 m

EBIT margin, %

(20%)(11%)(1%)46%

Interest expense

54 k208 k245 k136 k

Pre tax profit

(18.9 m)(9.9 m)(2.3 m)46.5 m

Income tax expense

(712 k)72 k(7 k)1.2 m

Net Income

(18.2 m)(10 m)(2.3 m)45.3 m

Quarterly

USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Revenue

24.1 m22.9 m24 m24.8 m23.1 m24 m25.2 m24.6 m26.4 m26.3 m26.3 m27.1 m27.7 m54.6 m80.3 m

Cost of goods sold

34.8 m

Gross profit

45.5 m

Gross profit Margin, %

57%

R&D expense

817 k832 k849 k791 k834 k809 k867 k861 k882 k822 k483 k766 k747 k1.6 m2.4 m

General and administrative expense

11.2 m10.5 m22 m33 m

Operating expense total

27.2 m26.5 m24.5 m27.9 m27 m26.8 m20.5 m17.1 m28.9 m822 k11.6 m11.3 m747 k58.3 m86.7 m

EBIT

(3 m)(3.6 m)(555 k)(3.1 m)(3.9 m)(2.8 m)4.6 m7.5 m(2.5 m)(1.3 m)(1 m)(227 k)(638 k)(3.7 m)(6.5 m)

EBIT margin, %

(13%)(15%)(2%)(12%)(17%)(12%)18%30%(10%)(5%)(4%)(1%)(2%)(7%)(8%)

Interest expense

62 k52 k47 k69 k49 k58 k40 k42 k40 k46 k79 k115 k157 k342 k569 k

Pre tax profit

(2.7 m)(3.6 m)(448 k)(3.6 m)(4.2 m)(3 m)4.5 m7 m(2.1 m)(1.5 m)(1 m)(39 k)(640 k)(2.6 m)(5.7 m)

Income tax expense

(63 k)4 k(7 k)(123 k)(87 k)(207 k)(2 k)(20 k)(53 k)(32 k)1.1 m1.1 m

Net Income

(2.8 m)(3.6 m)(455 k)(3.7 m)(4.1 m)(2.9 m)4.4 m6.8 m(2.1 m)(1.5 m)(1.1 m)(71 k)(640 k)(1.5 m)(4.6 m)

Enzo Biochem Balance Sheet

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

9 m17.5 m18.1 m67.8 m

Accounts Receivable

12.3 m12.5 m6.7 m6.7 m

Inventories

8.8 m8.7 m7.4 m7 m

Current Assets

32.6 m40.7 m46.5 m91.4 m

PP&E

8.6 m7.7 m7.9 m8.2 m

Goodwill

7.5 m7.5 m7.5 m7.5 m

Total Assets

59 m64.4 m68.4 m111.8 m

Current Liabilities

23.9 m25 m24 m20.6 m

Total Liabilities

22.3 m

Additional Paid-in Capital

304.3 m317.2 m325 m326.3 m

Retained Earnings

(272.4 m)(282.4 m)(284.7 m)(239.4 m)

Total Equity

34.1 m37 m42.6 m89.6 m

Financial Leverage

1.7 x1.7 x1.6 x1.2 x

Quarterly

USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Cash

7.4 m7.6 m14.8 m16.6 m15.3 m14.4 m30.6 m37 m32.4 m67.2 m62.4 m62.6 m66.8 m64.5 m62.6 m

Accounts Receivable

6.7 m6.7 m

Inventories

9.1 m9.2 m9 m8.5 m8.3 m8 m7.6 m7.4 m7 m7.2 m7.1 m7.2 m7.2 m7.5 m7.3 m

Current Assets

32.4 m30.6 m38.2 m39.7 m37 m36.1 m52.8 m59.2 m55.2 m90.4 m86.9 m87.5 m91 m89.5 m86.4 m

PP&E

8.5 m8.1 m7.8 m7.5 m7.6 m8 m8.1 m8.7 m8.6 m8.3 m8.2 m8.1 m7.8 m7.9 m8 m

Goodwill

7.5 m7.5 m7.5 m7.5 m7.5 m7.5 m7.5 m7.5 m7.5 m7.5 m7.5 m7.5 m7.5 m7.5 m7.5 m

Total Assets

58.3 m55.7 m62.5 m62.6 m59.5 m58.5 m74.4 m80.9 m76.5 m110.5 m106.4 m106.6 m109.3 m108.3 m105.5 m

Current Liabilities

24.2 m22.6 m22.1 m24.5 m22.7 m22.5 m25.8 m24.5 m21.7 m20.8 m17.6 m17 m19.5 m19.9 m18.7 m

Total Liabilities

25.2 m23.5 m24.6 m26.5 m24.7 m24.5 m27.2 m26.5 m23.5 m22 m18.7 m18 m20.1 m20.4 m19.1 m

Additional Paid-in Capital

306.1 m308.8 m315 m319.9 m322.7 m324.9 m325.1 m325.3 m326.1 m326.4 m326.8 m327.8 m330 m330.4 m330.5 m

Retained Earnings

(275.2 m)(278.8 m)(279.2 m)(286.1 m)(290.2 m)(293.1 m)(280.2 m)(273.4 m)(275.5 m)(240.9 m)(241.9 m)(242 m)(242.5 m)(243.4 m)(246.5 m)

Total Equity

47.2 m54.4 m53 m88.5 m87.7 m88.6 m89.2 m88 m86.4 m

Financial Leverage

1.6 x1.5 x1.4 x1.2 x1.2 x1.2 x1.2 x1.2 x1.2 x

Enzo Biochem Cash Flow

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(18.2 m)(10 m)(2.3 m)45.3 m

Accounts Receivable

(2.6 m)(3.2 m)(2 m)(4.8 m)

Inventories

60 k159 k1.2 m466 k

Cash From Operating Activities

(10 m)(1.7 m)(3.7 m)53.1 m

Cash From Investing Activities

(971 k)(833 k)(1.8 m)(1.5 m)

Cash From Financing Activities

4.8 m10.9 m6.2 m(1.9 m)

Free Cash Flow

(11 m)(2.5 m)(5.5 m)51.6 m

Quarterly

USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Net Income

(2.8 m)(6.4 m)(6.8 m)(3.7 m)(7.8 m)(10.7 m)4.4 m11.3 m9.2 m(1.5 m)(2.5 m)(2.6 m)(640 k)(1.5 m)(4.6 m)

Accounts Receivable

(2.3 m)(1.3 m)(2.5 m)(482 k)(524 k)(940 k)(1.4 m)(2 m)(3 m)(150 k)(2.2 m)(3.2 m)(101 k)(1.4 m)(1.2 m)

Inventories

(252 k)(381 k)(144 k)107 k306 k597 k(210 k)(20 k)447 k(298 k)(238 k)(213 k)(198 k)(430 k)(257 k)

Cash From Operating Activities

(3.3 m)(4.7 m)(2.7 m)(2.8 m)(6.5 m)(8.2 m)13.2 m20.1 m17 m(333 k)(2.8 m)(1.9 m)2.6 m835 k(475 k)

Cash From Investing Activities

(314 k)(472 k)(524 k)(259 k)(653 k)(1.2 m)(490 k)(941 k)(1.4 m)(514 k)(687 k)(1.4 m)(461 k)(1.1 m)(1.7 m)

Cash From Financing Activities

2 m3.7 m8.9 m2.2 m5.1 m6.4 m(125 k)(192 k)(1.4 m)303 k(1.8 m)(1.8 m)557 k520 k532 k

Free Cash Flow

(3.6 m)(5.1 m)(3.3 m)(3 m)(7.1 m)(9.3 m)12.6 m19.1 m15.6 m(847 k)(3.5 m)(3.3 m)2.1 m(231 k)(2.1 m)

Enzo Biochem Ratios

USDY, 2018

Financial Leverage

1.2 x
Report incorrect company information

Enzo Biochem Operating Metrics

FY, 2016

Facilities

2

Patents Issued

314

Patents Pending

146
Report incorrect company information